Therefore, the PSMA-4-1BB aptamer was able to increase lymphocyte infiltration in the tumor, but we did not prove whether that was the result of new lymphocytes homing to tumors driven by the bi-specific aptamer, or of in situ proliferation of already-infiltrated lymphocytes; those would be interesting studies to be done in the future. This evidence concerns the gene FOLH1 and neoplasm.